| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/06/2003 | CA2380202A1 Novel crude and crystalline forms of lercanidipine hydrochloride |
| 02/05/2003 | WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 02/05/2003 | EP1281962A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and an SH3 domain comprising peptide |
| 02/05/2003 | EP1281756A1 Regulator of calcineurin |
| 02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1281401A2 The medical effect of Jojoba oil |
| 02/05/2003 | EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 02/05/2003 | EP1280929A2 Vectors for ocular transduction and use thereof for genetic therapy |
| 02/05/2003 | EP1280918A2 Lipid metabolism enzymes |
| 02/05/2003 | EP1280911A2 Regulatory nucleic acid sequences of the ABC1 gene |
| 02/05/2003 | EP1280820A2 Anti-inflammatory compounds and uses thereof |
| 02/05/2003 | EP1280816A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 02/05/2003 | EP1280806A1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 02/05/2003 | EP1280805A1 Novel imidazotriazinones and the use thereof |
| 02/05/2003 | EP1280802A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280789A1 Cdk inhibitors having 3-hydroxychromen-4-one structure |
| 02/05/2003 | EP1280781A1 5-ht 7 receptor antagonists |
| 02/05/2003 | EP1280779A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280774A1 Substituted indoles as parp inhibitors |
| 02/05/2003 | EP1280759A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| 02/05/2003 | EP1280572A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280570A2 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280569A1 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280568A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280567A2 Nitric oxide-releasing metallic medical devices |
| 02/05/2003 | EP1280555A2 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 02/05/2003 | EP1280554A2 A pharmaceutical composition and method of treatment of diseases of cognitive dysfuntion in a mammal |
| 02/05/2003 | EP1280546A1 Method and composition for the treatment of angiogenesis |
| 02/05/2003 | EP1280537A2 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 02/05/2003 | EP1280533A2 Aldosterone antagonist composition for release during aldosterone acrophase |
| 02/05/2003 | EP1280526A1 Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| 02/05/2003 | EP1280523A2 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma |
| 02/05/2003 | EP1280522A2 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use |
| 02/05/2003 | EP1280512A2 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1223918B1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 02/05/2003 | EP1194145B1 Stable xylometazoline and oxymetazoline solution |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | EP1064009B9 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 02/05/2003 | EP1027329B1 Dofetilide polymorphs |
| 02/05/2003 | EP0980242B1 Use of fumaric acid derivatives for the treatment of autoimmune diseases |
| 02/05/2003 | EP0841913B1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 02/05/2003 | CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors |
| 02/05/2003 | CN1395575A Novel piperidine compounds and drugs containing the same |
| 02/05/2003 | CN1395574A Food product and producing method |
| 02/05/2003 | CN1395573A Extraction of flavonoids |
| 02/05/2003 | CN1395571A Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395567A New imidazole derivatives |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 02/05/2003 | CN1395555A Calcium dicarboxylate ethers, method of making same, and treatment of vascular disease and diabetes therewith |
| 02/05/2003 | CN1395488A Drospirenone for hormone replacement therapy |
| 02/05/2003 | CN1394860A 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it |
| 02/05/2003 | CN1394859A Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1394635A Wild chrysanthemum granules and preparation method |
| 02/05/2003 | CN1394615A Chinese medicine decoction for curing apoplectic hemiparalysis |
| 02/05/2003 | CN1394609A Puerarin oral preparation and its preparation method |
| 02/05/2003 | CN1394607A Buxining oral disintegrant tablet for curing angina pectoris and its preparation method |
| 02/05/2003 | CN1394606A Nifedipine drop pill preparation and its making method |
| 02/05/2003 | CN1394604A Indapamide slowly-releasing tablet |
| 02/05/2003 | CN1394603A Application of hydroxyethyl puerarin in preparation of new medicine for curing cerebrovascular diseases |
| 02/05/2003 | CN1394602A Benzoic acid substituted benzopyran fro curing atheroscleorsis |
| 02/05/2003 | CN1394597A Process for preparing powder preparation |
| 02/05/2003 | CN1100785C 1,3,4,5-tetrahydrobenzo [c] azepin-3-one disulfide derivative and method |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100747C Dialkyl ethers containing terinal caroxy or tetrazole group |
| 02/05/2003 | CN1100557C External-use Chinese medicine preparation for curing cerebrovascular disease |
| 02/05/2003 | CN1100552C Medicine for curing hemiparalysis |
| 02/05/2003 | CN1100551C Chinese patent drug for treating angiocardiopathy and cerebrovascular disease |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515136 To the novel intermediates prepared by these methods. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension. |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515130 The invention relates to a process of preparing (S-(R*,S*))-beta -(((1-(1-oxo-3-(4-piperidinyl)propyl)-3-piperidinyl) carbonyl)amino)-3-pyridinepropanoic acid derivatives represented by the antagonists of the platelet fibrinogen |
| 02/04/2003 | US6515117 C-aryl glucoside SGLT2 inhibitors and method |
| 02/04/2003 | US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6515025 Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6515012 Reacting 3-benzoylthio-2-methylpropionoic acid chloride with 4-phenylthio-L-proline; hypotnsive agents |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6515010 Carvedilol methanesulfonate |
| 02/04/2003 | US6515009 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 02/04/2003 | US6514989 Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514977 For treating p38 kinase mediated disorders |
| 02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/04/2003 | US6514971 Cinnoline derivatives and use as medicine |
| 02/04/2003 | US6514970 Urotensin-II receptor antagonists |
| 02/04/2003 | US6514968 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising |